TCRR
Wells Fargo’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-40,688
| Closed | -$61K | – | 7386 |
|
|
2023
Q1 | $61K | Buy |
40,688
+14,004
| +52% | +$21K | ﹤0.01% | 4775 |
|
|
2022
Q4 | $26.7K | Buy |
26,684
+16,471
| +161% | +$16.5K | ﹤0.01% | 4821 |
|
|
2022
Q3 | $18K | Buy |
10,213
+3,348
| +49% | +$5.9K | ﹤0.01% | 5141 |
|
|
2022
Q2 | $20K | Sell |
6,865
-4,737
| -41% | -$13.8K | ﹤0.01% | 5177 |
|
|
2022
Q1 | $32K | Sell |
11,602
-10,689
| -48% | -$29.5K | ﹤0.01% | 5514 |
|
|
2021
Q4 | $104K | Buy |
22,291
+74
| +0.3% | +$345 | ﹤0.01% | 5212 |
|
|
2021
Q3 | $189K | Sell |
22,217
-43,428
| -66% | -$369K | ﹤0.01% | 4833 |
|
|
2021
Q2 | $1.08M | Buy |
65,645
+4,524
| +7% | +$74.2K | ﹤0.01% | 3941 |
|
|
2021
Q1 | $1.35M | Buy |
61,121
+25,668
| +72% | +$567K | ﹤0.01% | 3783 |
|
|
2020
Q4 | $1.1M | Buy |
35,453
+1,901
| +6% | +$58.8K | ﹤0.01% | 3895 |
|
|
2020
Q3 | $682K | Sell |
33,552
-17,479
| -34% | -$355K | ﹤0.01% | 4034 |
|
|
2020
Q2 | $783K | Buy |
51,031
+29,879
| +141% | +$458K | ﹤0.01% | 3901 |
|
|
2020
Q1 | $163K | Buy |
21,152
+1,726
| +9% | +$13.3K | ﹤0.01% | 4630 |
|
|
2019
Q4 | $278K | Buy |
19,426
+10,960
| +129% | +$157K | ﹤0.01% | 4634 |
|
|
2019
Q3 | $127K | Buy |
8,466
+8,452
| +60,371% | +$127K | ﹤0.01% | 4992 |
|
|
2019
Q2 | $0 | Buy |
+14
| New | – | ﹤0.01% | 6282 |
|